Stock listing
Immucell Corporation
- Ticker
- NASDAQ:ICCC
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Immucell Corporation
The company focuses on developing innovative products for the veterinary market, particularly in the area of animal health. Immucell aims to enhance the well-being of livestock and pets through its specialized solutions.
Latest news from Immucell Corporation
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026
Aug 13, 2026
ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results
Jul 9, 2026
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026
May 14, 2026
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026
May 7, 2026